Search research articles
Contact Us
Filters
Showing results (11-20 of 56) with videos related to
Page
of 6
Sort By:
Human Mutation
|
January 8, 2013
Modeling tumor progression by the sequential introduction of genetic alterations into the genome of human normal cells
Davide Zecchin, Sabrina Arena, Miriam Martini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2013
Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET
Cristina Basilico, Selma Pennacchietti, Elisa Vigna, et al.
Nature Communications
|
June 9, 2017
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
Moiez Ali, Erin Kaltenbrun, Gray R Anderson, et al.
Human Mutation
|
November 21, 2007
PIK3CA cancer mutations display gender and tissue specificity patterns
Silvia Benvenuti, Milo Frattini, Sabrina Arena, et al.
Oncotarget
|
August 11, 2015
Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1
Shuai Lu, Helga-Paula Török, Eike Gallmeier, et al.
Cancers
|
March 10, 2022
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study
Alessio Amatu, Gianluca Mauri, Federica Tosi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer
Federica Di Nicolantonio, Miriam Martini, Francesca Molinari, et al.
ACS Biomaterials Science & Engineering
|
August 26, 2025
A Deep Learning Approach for Tracking Colorectal Cancer-Derived Extracellular Vesicles in Colon and Lung Models
Giulia Chiabotto, Bianca Dumontel, Luca Zilli, et al.
Cancer Biology & Therapy
|
January 17, 2004
p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells
Kurtis E Bachman, Brian G Blair, Keith Brenner, et al.
Cancer Treatment Reviews
|
October 22, 2020
Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities
Gianluca Mauri, Viviana Gori, Erica Bonazzina, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 56) with videos related to
Sort By:
Page
of 6
Human Mutation
|
January 8, 2013
Modeling tumor progression by the sequential introduction of genetic alterations into the genome of human normal cells
Davide Zecchin, Sabrina Arena, Miriam Martini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2013
Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET
Cristina Basilico, Selma Pennacchietti, Elisa Vigna, et al.
Nature Communications
|
June 9, 2017
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
Moiez Ali, Erin Kaltenbrun, Gray R Anderson, et al.
Human Mutation
|
November 21, 2007
PIK3CA cancer mutations display gender and tissue specificity patterns
Silvia Benvenuti, Milo Frattini, Sabrina Arena, et al.
Oncotarget
|
August 11, 2015
Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1
Shuai Lu, Helga-Paula Török, Eike Gallmeier, et al.
Cancers
|
March 10, 2022
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study
Alessio Amatu, Gianluca Mauri, Federica Tosi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer
Federica Di Nicolantonio, Miriam Martini, Francesca Molinari, et al.
ACS Biomaterials Science & Engineering
|
August 26, 2025
A Deep Learning Approach for Tracking Colorectal Cancer-Derived Extracellular Vesicles in Colon and Lung Models
Giulia Chiabotto, Bianca Dumontel, Luca Zilli, et al.
Cancer Biology & Therapy
|
January 17, 2004
p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells
Kurtis E Bachman, Brian G Blair, Keith Brenner, et al.
Cancer Treatment Reviews
|
October 22, 2020
Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities
Gianluca Mauri, Viviana Gori, Erica Bonazzina, et al.
Page
of 6